Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Danimer Scientific
AddedFeb 19, 2024
UpdatedJun 18, 2026
Danimer Scientific

Danimer Scientific

Public

Danimer Scientific: Global provider of sustainable, biodegradable biopolymers via innovative biotech processes.

HQ
Bainbridge, GA, US
Founded
2004
Overview
Compare
Fundraising
Employees
Website

Danimer Scientific was founded with the core mission of creating sustainable, biodegradable biopolymers to address the global plastic waste crisis. The company focuses on developing and manufacturing renewable biopolymers through innovative biotechnology processes. Their flagship product, Nodax®, is a % renewable and % biodegradable polymer used in various plastic packaging solutions. Danimer Scientific serves a global market, partnering with brand owners and plastics converters to provide eco-friendly alternatives to traditional plastics.

Notable affiliated individuals include key executives and scientists who have driven the company's research and development efforts. Danimer Scientific has attracted significant investment from environmentally-focused venture capital firms and strategic partners in the packaging industry. The company has achieved several key milestones, including commercializing Nodax® and forming partnerships with major consumer brands. Danimer Scientific's impact lies in its contribution to reducing plastic pollution and promoting sustainability in the plastics industry.

Danimer Scientific - Quick Facts

When was Danimer Scientific founded?

Danimer Scientific was founded in 2004.

Where is Danimer Scientific's headquarters located?

Danimer Scientific's headquarters is located in Bainbridge, GA, US.

When was Danimer Scientific's last funding round?

Danimer Scientific's most recent funding round was for $130M (USD) in March 2023.

How much has Danimer Scientific raised to-date?

As of Mar 20, 2023, Danimer Scientific has raised a total of $350.5M (USD).

How many employees does Danimer Scientific have?

Danimer Scientific has 271 employees as of Feb 6, 2024.

Danimer Scientific - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Manufacturing
Revenue
  • Recurring
Customer
  • Consumers
  • Enterprise
Main Product
  • Biopolymers
Tags
  • Biotech
  • Cleantech
NAICS
  • 320000Manufacturing
  • 325200Resin, Synthetic Rubber, and Artificial and Synthetic Fibers and Filaments Manufacturing
  • 325210Resin and Synthetic Rubber Manufacturing
  • 325211Plastics Material and Resin Manufacturing
  • 325000Chemical Manufacturing
SIC
  • 2820Plastics Materials And Synthetic Resins, Synthetic Rubber, Cellulosic Manmade Fibers
  • 2821Plastics Materials, Synthetic Resins, And Nonvulcanizable Elastomers
  • 2800Chemicals And Allied Products
ISIC
  • 2013Manufacture of plastics and synthetic rubber in primary forms
Show 7 more industry codes
NAICS
  • 325212Synthetic Rubber Manufacturing
SIC
  • 2822Synthetic Rubber (Vulcanizable Elastomers)
  • 2890Miscellaneous Chemical Products
  • 2899Chemicals And Chemical Preparations, Not Elsewhere Classified
  • 4000Railroad Transportation
  • 5000Wholesale Trade-durable Goods
  • 6700Holding And Other Investment Offices